CD8A and cancer: For instance, PD-1/PD-L1 blockade can increase the amount of IFN-γ secreted by CD8+ T cells, which in turn trigger tumor cells to upregulate the Wnt/β-catenin signaling and accelerate the progression of malignant cancers [50].